Reducing Recidivism in Alaska Throough Access to Extended-Release Injectable Naltrexone
dc.contributor.author | Green, Jyll K. | |
dc.date.accessioned | 2017-08-03T22:56:22Z | |
dc.date.available | 2017-08-03T22:56:22Z | |
dc.date.issued | 2016-12-01 | |
dc.identifier.uri | http://hdl.handle.net/11122/7797 | |
dc.description | A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF NURSING PRACTICE in Nursing | en_US |
dc.description.abstract | The goal of this evidence-based project was to provide access to extended-release injectable naltrexone (XR-NTX) upon release from incarceration for individuals who had a self-identified substance or alcohol abuse history, and evaluate whether or not XR-NTX reduced recidivism in comparison with those who declined to use XR-NTX. This project was completed in collaboration with Partners Reentry Center, located in Anchorage, Alaska, who collected and offered retrospective de-identified data for this project. A total of 98 individuals with a self-identified history of substance or alcohol abuse were offered XR-NTX through Partners Reentry Center from September 15, 2015 to September 15, 2016. Of these, 52 were offered XR-NTX in the first six months of this evidenced-based quality improvement project. Of those who accepted XR-NTX (n = 32), 62% remained in the community at the end of 12 months from project initiation. Of those who declined XR-NTX (n = 20), 95% recidivated. The results of this project demonstrate the benefit of using XR-NTX in released prisoners to reduce recidivism. Implications for use the of XR-NTX in Alaska Department of Corrections inmates and the general population who meet criteria for use should be evaluated. | en_US |
dc.description.tableofcontents | Title Page / List of Figures / List of Tables / List of Appendices / Overview of the Problem of Interest / Review of the Literature / Organizational Framework / Project Design / Implementation Process and Procedures / Evaluation and Project Outcomes / Implications for Nursing Practice / Summary and Conclusion / References / Appendices | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | University of Alaska Anchorage | en_US |
dc.subject | extended-release injectable naltrexone | en_US |
dc.subject | recidivism | en_US |
dc.title | Reducing Recidivism in Alaska Throough Access to Extended-Release Injectable Naltrexone | en_US |
dc.type | Thesis | en_US |
refterms.dateFOA | 2020-03-05T12:50:33Z |